Market Pulse

Latest company updates, ordered by publication date.

OneMedNet Corporation

OneMedNet Bookings Surge 4x, Signals Shift to Subscription Model

Event summary

  • OneMedNet reported $2.79 million in bookings for 2025, a 4.1x increase compared to $684,000 in 2024.
  • The company attributes the booking growth to larger deal sizes and increased enterprise demand for AI-powered Real-World Data (RWD).
  • OneMedNet is actively transitioning from project-based engagements to a recurring subscription model, evidenced by agreements with Circle CVI and mlHealth360.
  • New product offerings include Subscription Search (powered by Palantir Foundry) and Subscription Data License, priced higher than traditional data projects.

The big picture

OneMedNet's accelerated booking growth and strategic shift towards a subscription model reflect a broader trend in the healthcare data space, where real-world data is increasingly critical for AI model development and regulatory approvals. The company’s reliance on Palantir Foundry to deliver these subscription services positions it within a growing market for enterprise AI platforms, but also introduces a dependency risk. The success of this transition will be a key indicator of OneMedNet’s ability to capitalize on the increasing demand for RWD and establish a durable, recurring revenue stream.

What we're watching

ARR Trajectory
The sustainability of the ARR growth hinges on OneMedNet’s ability to convert existing data project clients to subscription agreements and expand within those accounts.
Palantir Dependency
OneMedNet’s reliance on Palantir Foundry for key product features introduces a potential risk if the partnership weakens or Palantir’s pricing structure changes.
Competitive Landscape
The success of OneMedNet’s premium subscription offerings will depend on its ability to differentiate its value proposition from competitors offering similar RWD and AI-powered analytics solutions.
Tenable Holdings, Inc.

Tenable Claims 'Company to Beat' in Gartner AI Exposure Assessment

Event summary

  • Tenable has been recognized by Gartner as the 'Current Company to Beat' in AI-powered exposure assessment, according to a December 2025 report.
  • Gartner credits Tenable's position to its combination of vulnerability assessment, asset discovery, third-party telemetry ingestion, and AI.
  • Tenable attributes its success to its 'Tenable One' platform, which aims to unify and contextualize risk exposure data.
  • The report highlights Tenable's strategy of creating a 'pane of glass' for exposure data to improve AI analysis and remediation workflows.
  • Tenable's CTO, Vlad Korsunsky, emphasizes the importance of leveraging AI for both defense and securing AI itself.

The big picture

The Gartner recognition underscores the growing importance of AI in cybersecurity, with exposure assessment becoming increasingly reliant on automated analysis and threat prioritization. Tenable's success highlights a shift away from traditional vulnerability management towards a more holistic, risk-aware approach. This validation positions Tenable to capitalize on the expanding market for AI-powered security solutions, but also intensifies competition within a rapidly evolving landscape.

What we're watching

Competitive Response
Other cybersecurity vendors will likely accelerate their AI initiatives to challenge Tenable's position, potentially leading to increased price pressure and feature parity.
Client Adoption
The pace at which Tenable can convert Gartner's endorsement into increased enterprise adoption of 'Tenable One' will determine the long-term impact on revenue growth.
Data Dependency
How effectively Tenable manages the increasing volume and complexity of data ingested into its platform will be critical to maintaining its AI-driven advantage.
Canadian Labour Congress / Congrès du travail du Canada

Canadian Unions Demand Public Disclosure of Corporate Tax Data

Event summary

  • The Canadian Labour Congress (CLC), PSI, and ITUC are jointly urging the Canadian government to mandate public country-by-country reporting (pCbCR) for large multinational corporations.
  • pCbCR would require public disclosure of profit generation, worker locations, and tax payments, data already collected by Canadian authorities.
  • An estimated $22–25 billion in corporate profits are currently shifted out of Canada annually.
  • The unions argue this shift weakens worker bargaining power and reduces revenue for public services.

The big picture

The union's push for pCbCR reflects a growing global trend towards greater corporate accountability and a backlash against perceived tax avoidance strategies. Canada's current stance contrasts with the EU and Australia, highlighting a divergence in regulatory approaches. This issue has significant implications for government revenue, worker wages, and the overall competitiveness of Canadian businesses.

What we're watching

Political Response
The likelihood of the Canadian government adopting pCbCR hinges on upcoming elections and the influence of lobbying efforts from multinational corporations.
Investor Scrutiny
Increased public awareness of corporate tax practices, even without mandated reporting, will likely intensify investor pressure for greater transparency.
Competitive Disadvantage
Canadian corporations may face a competitive disadvantage if pCbCR is implemented, potentially impacting investment decisions and job creation.
Guidehouse Inc.

Healthcare AI Investment Stalled by Execution Gaps

Event summary

  • A Guidehouse-HIMSS survey found 78% of health systems are currently engaged in AI projects.
  • However, only 52% of healthcare executives feel their organizations are operationally ready to implement AI at scale.
  • Key obstacles include cybersecurity concerns (48%), budget limitations (48%), data quality issues (42%), and lack of expertise/alignment (36%).
  • The survey was based on responses from 50 healthcare leaders and published in Guidehouse's 2026 Healthcare AI Trends report.

The big picture

Despite significant investment in AI solutions, healthcare organizations are struggling to translate those investments into operational reality. This 'execution paralysis' highlights a broader challenge in the industry: the difficulty of integrating new technologies into complex, highly regulated environments. The gap between AI investment and readiness suggests a potential slowdown in the pace of AI adoption within healthcare, and a need for more holistic, strategic approaches to implementation.

What we're watching

Governance Dynamics
The need for a cohesive, system-wide AI strategy will likely drive increased demand for consulting services, benefiting firms like Guidehouse, but also creating a potential bottleneck for adoption if not addressed quickly.
Workforce Impact
The report's emphasis on redesigning roles for an AI-augmented workforce suggests a significant shift in healthcare employment, potentially requiring substantial retraining programs and impacting labor costs.
Data Standards
The persistent concerns around data quality and governance indicate that standardization efforts will be critical for unlocking the full potential of AI in healthcare, and may require significant investment in data infrastructure.
Ivalua Inc.

Masdar City's AI-Powered Procurement Cuts Costs, Boosts Productivity

Event summary

  • Masdar City won the 'Best Procurement Technology Implementation' award at the Middle East Procuretech & Supply Chain Innovation Summit 2026.
  • The city consolidated five legacy procurement systems into a single Ivalua Source-to-Pay platform with embedded Generative AI.
  • Masdar City achieved a 95% reduction in administrative effort for contract management and an 80% increase in buyer productivity.
  • Masdar City separated from Masdar (Abu Dhabi Future Energy Company) in late 2022 to maximize contributions to the UAE.
  • Masdar City’s free zone hosts over 2,000 organizations, including IRENA, the UAE Space Agency, and Siemens Energy.

The big picture

Masdar City's procurement transformation highlights the growing importance of AI-powered automation in complex, regulated environments. The 95% reduction in administrative effort demonstrates the potential for significant cost savings and productivity gains. This deployment serves as a proof-of-concept for Ivalua, positioning them to target similar large-scale, government-backed initiatives focused on sustainability and digital modernization.

What we're watching

Governance Dynamics
The separation of Masdar City from Masdar (Abu Dhabi Future Energy Company) warrants monitoring to assess the long-term strategic implications for both entities and their respective procurement strategies.
AI Scalability
The success of Ivalua's Generative AI integration within Masdar City’s procurement function will influence its adoption rate across other complex, regulated environments.
Regulatory Impact
Continued adherence to UAE regulatory and information security requirements will be critical for Masdar City and could serve as a benchmark for other organizations deploying similar platforms.
CSX Corporation

CSX CEO to Address Barclays Industrial Conference Amid Rail Sector Scrutiny

Event summary

  • CSX President and CEO Steve Angel will speak at the Barclays Industrial Select Conference on February 19, 2026.
  • The conference is the 43rd annual iteration, taking place in Miami Beach.
  • Angel's address will be webcast live and a replay will be available on CSX's investor relations website.
  • CSX operates a rail network connecting major metropolitan areas in the eastern US and links to numerous short-line railroads and ports.

The big picture

CSX's participation in the Barclays conference occurs at a time when the rail industry faces heightened regulatory attention and evolving customer demands. The conference appearance offers a platform for CSX to address investor concerns and articulate its strategy for navigating these challenges. The event's focus on industrial sectors highlights CSX's crucial role in supporting broader economic activity and its exposure to cyclical industrial demand.

What we're watching

Regulatory Headwinds
Increased scrutiny of rail freight rates and service quality, particularly following recent supply chain disruptions, may be a key topic of discussion and could influence CSX's strategic outlook.
Capital Allocation
Angel's comments regarding CSX's capital expenditure plans, particularly concerning precision rail technology and infrastructure upgrades, will signal the company's commitment to operational efficiency and future growth.
Competitive Landscape
The conference provides an opportunity to gauge CSX's perspective on the competitive pressures from trucking and intermodal services, and how the company intends to maintain its market share.
Black Mammoth Metals Corporation

Black Mammoth Metals Identifies Chargeability Anomaly Near Gold Zone in Nevada

Event summary

  • Black Mammoth Metals has identified a chargeability anomaly at the Happy Cat South target within the South Ravenswood property in Nevada.
  • The anomaly is coincident with a gravity high and located east of a 600-meter diameter gold mineralization zone, extending open to the north and south.
  • The company has staked 66 additional lode claims (approximately 551 hectares) on BLM land.
  • Previous exploration has confirmed a gold mineralization zone, but the source remains unidentified.

The big picture

The discovery of this geophysical anomaly at Happy Cat South represents a potentially significant development for Black Mammoth Metals, suggesting a possible new vector for gold exploration within the Rabbit Creek Gold Trend. The coincident gravity high and chargeability anomaly may indicate a deeper, structurally controlled mineralization system, which could expand the resource footprint beyond the currently known gold zone. Successful exploration at Happy Cat South could substantially increase the company’s value proposition in a region known for its gold potential.

What we're watching

Drill Targeting
The success of inversion modeling and subsequent drill targeting will be crucial in determining the extent and grade of the mineralization associated with the anomaly.
Exploration Budget
Given the open nature of the anomaly, Black Mammoth will need to allocate sufficient capital to expand the IP survey and conduct targeted drilling.
Mineralization Source
Whether the anomaly represents a previously unknown source of mineralization or is related to the existing, unexplained gold zone will significantly impact the project's potential.
M-tron Industries, Inc.

Mtron Secures $4 Million Follow-On for Air Defense Contract

Event summary

  • Mtron received a $4 million follow-on order for a production contract, bringing the total contract value to approximately $24 million.
  • The original contract, announced in December 2025, was valued at roughly $20 million and supports a major air defense program.
  • The contract now includes higher annual unit volumes, additional RF products, and a two-year production commitment, previously limited to twelve-month cycles.
  • Work on the contract will be performed at Mtron's Orlando, Florida facility through mid-2028.

The big picture

This follow-on award underscores Mtron's position as a key supplier within the U.S. and allied air defense infrastructure, a sector experiencing increased investment due to ongoing geopolitical tensions. The two-year commitment signals a deeper level of trust from the defense prime, but also increases Mtron’s exposure to the program’s long-term viability. The contract’s expansion suggests a growing demand for Mtron’s specialized RF components, but also highlights the importance of maintaining a competitive cost structure within the defense supply chain.

What we're watching

Program Longevity
The contract's reliance on a program expected to continue beyond 2030 suggests a potentially stable revenue stream, but also exposes Mtron to risks associated with shifting geopolitical priorities and defense budget allocations.
Prime Dependency
Mtron's dependence on a 'major defense prime' highlights a concentration risk; further contract wins from diverse customers will be crucial for long-term stability.
Production Scaling
The expanded unit volumes and product range will test Mtron's production capacity and supply chain management capabilities, potentially impacting margins if not executed efficiently.
Oncotelic Therapeutics, Inc.

Oncotelic Bolsters CNS IP, Eyes Parkinson's Treatment Pathway

Event summary

  • Oncotelic Therapeutics and Sapu Bioscience secured patent claims in Australia for OT-101’s treatment of Parkinson’s Disease, including sleep-related symptoms.
  • Utility model patents for an intracranial drug delivery device were granted in China and Germany, extending protection through 2033.
  • Oncotelic is building a 'Patent Wall' around OT-101, covering therapeutic use, CNS delivery, device administration, and biomarker-driven patient selection.
  • Oncotelic will present data on OT-101 and its Deciparticle™ platform at BIO-Europe Spring on March 23-25, 2026.

The big picture

Oncotelic's expansion of its IP coverage for OT-101 signals a strategic pivot towards neurology and CNS applications, leveraging a previously oncology-focused asset. This move reflects the broader trend of repurposing existing drug candidates to address unmet needs in neurological disorders, a market segment with significant commercial potential. The company's emphasis on device-level protection highlights the increasing importance of specialized drug delivery technologies in CNS therapeutics.

What we're watching

Clinical Efficacy
The success of OT-101 in treating Parkinson’s Disease and related sleep disorders will hinge on demonstrating efficacy in larger, controlled clinical trials, given its prior oncology focus.
Delivery Adoption
The adoption rate of the newly patented intracranial delivery device will be critical for OT-101’s CNS therapeutic potential, as it represents a novel administration route.
Partnering Strategy
Oncotelic’s ability to leverage its strengthened IP portfolio to secure strategic partnerships for development and commercialization will be a key indicator of long-term value creation.
PTC Inc.

SPG Company Modernizes PLM with PTC FlexPLM to Support Licensed Product Growth

Event summary

  • SPG Company, a licensed product design and distribution firm, has selected PTC’s FlexPLM to replace its legacy PLM system.
  • The move aims to address performance issues, data inconsistencies, and workflow bottlenecks hindering product development.
  • SPG’s existing PLM system had become complex and heavily customized, limiting scalability.
  • PTC is positioning FlexPLM as a key component of its 'Intelligent Product Lifecycle' vision, enabling AI-driven transformation.

The big picture

SPG Company’s decision to modernize its PLM system highlights the growing pressure on licensed product companies to accelerate development cycles and improve data consistency in a competitive market. The move also underscores the increasing importance of cloud-based PLM solutions for scalability and collaboration, particularly as companies expand their product portfolios and customer bases. PTC’s win demonstrates its continued success in targeting retail and consumer product organizations with its FlexPLM offering.

What we're watching

Implementation Risk
The success of this initiative hinges on SPG’s ability to smoothly migrate from its legacy system to FlexPLM, minimizing disruption to ongoing product development cycles.
Data Integration
The effectiveness of FlexPLM will depend on how well it integrates with SPG’s other enterprise systems and the accuracy of the data migrated from the old platform.
AI Adoption
The extent to which SPG leverages FlexPLM’s capabilities to accelerate AI-driven product development and optimization will be a key indicator of the platform’s long-term value.
Willis Lease Finance Corporation

Willis Lease Finance Builds Engine Restoration Capability to Bolster Lifecycle Services

Event summary

  • Willis Lease Finance Corporation (WLFC) has completed its first core engine restoration at its U.S.-based Willis Engine Repair Center.
  • The restored engine module was a CFM56-7B core, demonstrating strong exhaust gas temperature (EGT) margin recovery.
  • The new in-house capability is branded Willis Module Shop™.
  • WLFC's CEO, Austin C. Willis, stated the move aims to reduce maintenance expenses and enhance control over turnaround times.

The big picture

Willis Lease Finance's move to bring core engine module restoration in-house represents a strategic shift towards greater vertical integration and control over its engine lifecycle services. This capability complements existing offerings like ConstantThrust® and ConstantAccess®, positioning WLFC to better navigate the ongoing transition in the aviation industry from legacy to next-generation platforms. By capturing more value within its operations, WLFC aims to improve asset utilization and long-term portfolio returns, potentially differentiating itself from competitors who rely on external MRO providers.

What we're watching

Cost Impact
The extent to which in-house restoration reduces WLFC's overall maintenance costs and improves margins will be a key indicator of the initiative's success.
Competitive Response
Competitors in the aircraft engine leasing and MRO space may react by developing similar in-house capabilities or adjusting pricing strategies.
Scalability
The pace at which Willis Module Shop™ expands its restoration capabilities to support a wider range of engine models will determine its long-term strategic impact.
J.S. Held

Intangible Assets Now Dominate S&P 500 Market Value, Study Finds

Event summary

  • Ocean Tomo's 2025 Intangible Asset Market Value (IAMV) study reveals intangible assets now comprise approximately 92% of the S&P 500's market capitalization, compared to 8% for tangible assets – a complete reversal from 1975.
  • The study leverages 50 years of US market data and 20 years of foreign market data to analyze the components of market value.
  • Between 1985 and 2005, the share of intangible assets in the S&P 500 surged from 32% to 79%.
  • Despite aggressive monetary tightening by the Federal Reserve from 2020-2025, IAMV remained stable at roughly 90%, defying traditional financial theory.

The big picture

The shift towards intangible asset dominance represents a fundamental restructuring of corporate value, mirroring the scale of the Industrial Revolution. This trend has significant implications for investment strategies, corporate governance, and the measurement of economic performance, potentially requiring a rethinking of traditional valuation methodologies and risk assessment frameworks. The stability of IAMV despite rate hikes suggests a decoupling of traditional economic indicators from corporate valuation, a phenomenon that demands deeper analysis.

What we're watching

Theoretical Challenge
The stability of IAMV during monetary tightening warrants further investigation, potentially requiring a re-evaluation of traditional financial models and their applicability to intangible-heavy companies.
International Adoption
The study's expansion to international markets suggests a broader trend of intangible asset dominance; the pace at which these shifts occur in other economies will be a key indicator of global economic evolution.
Valuation Practices
How financial institutions increasingly recognize and incorporate intangible assets into their valuation practices will determine the accessibility of capital for companies reliant on intellectual property.
Kohler Co.

Kohler's Recirculating Shower Aims to Disrupt Luxury Bath Fixtures

Event summary

  • Kohler launched the Anthem EvoCycle smart shower, a recirculating dual-mode system, on February 12, 2026.
  • The system claims to save up to 80% of water while maintaining full flow rate.
  • The shower incorporates ozone cleaning features and integrates with Kohler Konnect app for remote control and usage tracking.
  • Kohler is showcasing the Anthem EvoCycle at KBIS 2026 with a fully interactive display.

The big picture

Kohler's Anthem EvoCycle represents a strategic shift towards integrating sustainability and smart technology into its luxury product line. This move aligns with growing consumer demand for eco-friendly home solutions and addresses increasing water scarcity concerns. The high price point and complex installation suggest a focus on the premium segment, potentially limiting broader market penetration but establishing Kohler as a leader in sustainable luxury.

What we're watching

Adoption Rate
The success of Anthem EvoCycle hinges on convincing luxury homeowners and builders to adopt recirculating shower technology, which may require significant education and upfront investment.
Competitive Response
Other bath fixture manufacturers will likely accelerate their own sustainability initiatives, potentially leading to a price war or a race to develop competing technologies.
Regulatory Impact
Increasingly stringent water conservation regulations in key markets could drive demand for water-saving technologies like EvoCycle, but also create compliance burdens for Kohler.
Tradeweb Markets Inc.

Tradeweb Invests in MAXEX to Expand Private Mortgage Market Access

Event summary

  • Tradeweb has made a strategic investment in MAXEX, a digital exchange for U.S. residential mortgage loans, with financial terms undisclosed.
  • The collaboration aims to connect Tradeweb’s network of over 3,000 clients with MAXEX’s network of approximately 400 lenders and 36+ investors.
  • MAXEX facilitates loan sales into over 250 private-label securitizations and serves as a liquidity expediter for private mortgage loans.
  • Tradeweb appointed Troy Dixon and Marc Simpson to MAXEX’s Board of Directors as part of the investment.
  • The move expands Tradeweb’s mortgage footprint beyond agency MBS into the private residential credit ecosystem.

The big picture

Tradeweb's investment in MAXEX signals a broader trend of institutional investors seeking higher yields in private credit markets, bypassing traditional GSE channels. This move also highlights the ongoing digitization of the mortgage market, addressing long-standing fragmentation and operational inefficiencies. The collaboration represents a significant expansion for Tradeweb beyond its established agency MBS business, positioning it to capitalize on the growing demand for private residential credit.

What we're watching

Integration Risk
The success of the collaboration hinges on the seamless integration of Tradeweb’s and MAXEX’s platforms, which could face technical and operational challenges.
Regulatory Scrutiny
Increased institutional activity in the private mortgage market may draw regulatory attention, potentially impacting the operational model of both Tradeweb and MAXEX.
Competition
The expansion of electronic trading in private mortgages will likely attract new entrants and intensify competition, potentially impacting MAXEX’s market share and Tradeweb’s revenue growth.
Intact Financial Corporation

Intact Financial Authorizes $360M Share Buyback

Event summary

  • Intact Financial Corporation has received TSX approval for a normal course issuer bid (NCIB) to repurchase up to 5,326,847 common shares, representing approximately 3% of outstanding shares.
  • The NCIB is authorized for cancellation over the next 12 months, commencing February 17, 2026, and expiring February 16, 2027.
  • During the previous 12-month period, Intact purchased 798,825 shares at an average price of $270.55.
  • Daily purchase limits are set by TSX rules, allowing for a maximum of 108,504 shares daily.

The big picture

Intact's NCIB signals a willingness to return capital to shareholders, potentially reflecting confidence in the company's financial health and a lack of compelling alternative investment opportunities. This move is common among large, mature companies with strong cash flow, and can be viewed as a positive signal for investor sentiment. The buyback program, combined with Intact's expansion into new markets and focus on data and AI, underscores its commitment to long-term growth and shareholder value.

What we're watching

Capital Deployment
The scale of the buyback ($360M) suggests Intact believes its shares are undervalued, or that other investment opportunities are less attractive. Monitoring future capital allocation decisions will reveal if this is a one-off event or a shift in strategy.
Shareholder Perception
The average purchase price in the prior NCIB ($270.55) provides a benchmark. Future buyback activity and pricing will be scrutinized to assess whether Intact is delivering value to shareholders.
Market Conditions
The NCIB's execution will be influenced by broader market volatility and interest rate movements, which could impact Intact's share price and the overall effectiveness of the program.
LiveOne, Inc.

LiveOne Shrinks Staff, Repurchases Shares Amidst Revenue Decline

Event summary

  • LiveOne reported $58.2 million in nine-month fiscal 2026 revenue, a 42% decrease year-over-year.
  • The company reduced operating expenses by 52% year-over-year through AI-driven efficiencies and slashed staff from 350 to 88.
  • LiveOne is expanding its share repurchase program with approximately $6 million remaining under the current authorization.
  • The Audio Division projects revenue of $85-$95 million and adjusted EBITDA of $8-$10 million for Fiscal 2027.

The big picture

LiveOne's results highlight the challenges facing music and entertainment platforms in a rapidly evolving digital landscape. The aggressive cost-cutting measures and share buybacks suggest management's focus on short-term shareholder value, while the revenue decline underscores the need for a sustainable growth strategy. The company's reliance on a single Fortune 250 partner and the potential for M&A activity introduce further uncertainty.

What we're watching

Revenue Sustainability
Whether LiveOne can reverse the revenue decline, particularly given the reduced contribution from Slacker, will be critical to assessing the platform's long-term viability.
AI Efficiency
The effectiveness of AI-driven efficiencies in sustaining margin expansion, beyond the initial 52% reduction, warrants close monitoring.
B2B Partnerships
The success of the planned B2B partnership reaching 30 million subscribers will be a key indicator of LiveOne's ability to expand its user base and revenue streams.
Oryzon Genomics, S.A.

Oryzon Taps Atai Exec to Drive CNS Program into Phase III

Event summary

  • Rolando Gutierrez-Esteinou, M.D. has been appointed Chief Medical Officer for CNS Programs at Oryzon Genomics.
  • Dr. Gutierrez-Esteinou previously served as CMO at Atai Life Sciences.
  • He brings over 20 years of experience in CNS drug development, including late-stage execution and regulatory strategy.
  • Oryzon plans to advance vafidemstat, its lead CNS program, into Phase III trials for agitation and aggression in borderline personality disorder.
  • Dr. Michael Ropacki, the previous CMO–CNS, is being recognized for his six years of service.

The big picture

Oryzon’s move to recruit a seasoned executive like Dr. Gutierrez-Esteinou signals a heightened focus on advancing its vafidemstat program, which targets a significant unmet need in CNS disorders. The company’s strategy of leveraging epigenetic mechanisms represents a potentially disruptive approach to treating psychiatric conditions, but also carries regulatory and clinical execution risks. This appointment underscores the increasing trend of biopharma companies seeking specialized expertise to navigate the complexities of CNS drug development.

What we're watching

Clinical Execution
The success of Oryzon’s Phase III trial for vafidemstat will hinge on Dr. Gutierrez-Esteinou’s experience in late-stage CNS development, given the complexity of BPD and the need for robust efficacy data.
Regulatory Pathway
The FDA and EMA will likely scrutinize Oryzon’s epigenetic approach to CNS disorders, and Dr. Gutierrez-Esteinou’s prior regulatory interactions will be critical in navigating potential hurdles.
Pipeline Expansion
Oryzon’s stated intention to expand vafidemstat’s clinical development into autism and schizophrenia will require significant resources and may dilute focus from the initial BPD indication.
PodcastOne, Inc.

PodcastOne Revenue Surges, Eyes $75M Revenue Run Rate

Event summary

  • PodcastOne reported record nine-month revenue of $46 million, up 21% year-over-year.
  • Adjusted EBITDA for the nine-month period reached $4.5 million, a 421% increase year-over-year.
  • The company is guiding for full-year 2026 revenue of $68-$75 million and Adjusted EBITDA of $6-$10 million.
  • PodcastOne expanded its Amazon partnership from $16.5 million to a $20+ million annual run rate and achieved $27+ million in revenue from a Fortune 250 streaming partner.

The big picture

PodcastOne's strong performance reflects the continued growth of the podcasting market and the increasing monetization opportunities within the space. The company's focus on strategic partnerships and content acquisition has driven significant revenue and profitability gains, but its reliance on a few key relationships presents a potential risk. The Paramount acquisition of Varnamtown highlights the broader industry trend of consolidation and the value placed on podcast content and networks.

What we're watching

Guidance Sustainability
Whether PodcastOne can achieve its ambitious revenue and EBITDA guidance, particularly given the reliance on a few key partnerships, will be a key indicator of long-term viability.
Content Dependency
The continued success of flagship shows and the ability to attract and retain top podcasters will be crucial for maintaining subscriber growth and revenue momentum.
Partner Risk
The concentration of revenue within a few large partners, particularly Amazon and the Fortune 250 streaming partner, exposes PodcastOne to potential contract renegotiations or loss of business.
Pacira BioSciences, Inc.

NOPAIN Act Data Shows Early Adoption, Boosts Pacira's Non-Opioid Push

Event summary

  • A survey of 750 hospital and ASC directors found 85% were aware of the NOPAIN Act.
  • 52% of facilities surveyed have taken steps to increase the use of non-opioid pain management options.
  • 83% of respondents reported decreased opioid prescribing immediately after surgery, and 88% at discharge.
  • The NOPAIN Act went into effect on January 1, 2025, as part of the Consolidated Appropriations Act of 2023.

The big picture

The NOPAIN Act represents a significant shift in pain management practices, driven by mounting pressure to address the opioid crisis. Pacira, as a leading provider of non-opioid alternatives, is positioned to benefit from this regulatory tailwind, but its success hinges on broader adoption across the healthcare system and sustained clinical efficacy.

What we're watching

Commercial Adoption
While Medicare adoption is evident, the pace at which commercial payers follow suit will be critical for Pacira's long-term revenue growth and market penetration.
Protocol Shifts
The sustainability of the reported protocol changes within hospitals and ASCs will depend on ongoing education, reimbursement models, and potential resistance from surgeons or anesthesiologists.
Competitive Landscape
How other non-opioid pain management companies respond to the NOPAIN Act and Pacira's market position will shape the competitive dynamics within the sector.
Fidelity National Information Services, Inc.

FIS Treasury Solutions Garner Broad Recognition Amid Rising Financial Risk

Event summary

  • FIS received the 'Best Risk Management Solution' and 'Best Cash & Treasury Management Solution' at the 2026 TMI Awards, marking the eighth and seventh consecutive year for the latter.
  • IDC MarketScape positioned FIS as a Leader in AI-Enabled Enterprise Treasury and Risk Management Applications for 2025-2026.
  • Chartis recognized FIS as a Category Leader across all six quadrants of its Asset and Liability Management (ALM) Solutions report.
  • FIS's recognition highlights its breadth across treasury, risk, accounting, and payments hub capabilities.

The big picture

FIS's consistent recognition underscores the growing importance of sophisticated treasury and risk management solutions in a volatile financial environment. Rising payment fraud costs and market volatility are forcing institutions to prioritize liquidity and compliance, creating a significant tailwind for vendors like FIS. The emphasis on AI integration suggests a broader industry shift towards automation and predictive analytics within treasury functions, potentially reshaping the competitive landscape.

What we're watching

AI Integration
The structured path to AI-assisted operations, as highlighted by IDC MarketScape, will be crucial to monitor; FIS’s success hinges on translating this approach into tangible client value and demonstrable ROI.
Competitive Landscape
Given the crowded vendor landscape for treasury and risk management solutions, FIS must differentiate its offerings beyond awards and reports to maintain its leadership position and fend off emerging competitors.
Regulatory Scrutiny
Increased regulatory pressure on financial institutions to manage liquidity and mitigate risk will likely drive demand for solutions like FIS’s, but also necessitate ongoing adaptation and investment to maintain compliance.